摘要
阿尔茨海默病(AD)是一种以记忆渐进性丧失和空间定向障碍为特点的疾病,我们发现成年海马神经改变(AN)在AD发病机制中起着关键作用。糖尿病是一个导致散性发阿尔茨海默病(sAD)发生的危险因素,它影响超过95%的AD患者。用链脲佐菌素侧脑室注射治疗大鼠将造成一种抗胰岛素的脑状态,学习和记忆能力的缺失发生在淀粉样β、tau蛋白病之前,即建立一个合适的sAD动物模型。定量免疫组织化学研究的目的是比较链脲佐菌素侧脑室注射治疗对不同AN阶段的短期(1个月)和长期(3个月)影响。我们应用MCM2抗体量化细胞(如干细胞)增殖,通过使用NeuroD和DCX抗体分析未成熟神经元。BrdU标记和大约27天的生存考验让我们得以量化和识别幸存的新生细胞。抗体检测BrdU标记的共定位研究和特异性标记表明STZ治疗不影响新生成细胞的分化过程。而链脲佐菌素侧脑室注射治疗似乎并没有显著影响在短期内(1个月)的细胞增殖,但在长期(3个月)后一代未成熟和成熟的神经元显著降低。3个月后的神经元减少对间隔海马体来说十分特殊,它对老鼠的空间学习产生重要影响。此外,在这个sAD的动物模型中,AN变化与β淀粉样蛋白病的发展显示出了相同的时间轴。
关键词: 成年神经再生
Current Alzheimer Research
Title:Long-Term Effects of Intracerebroventricular Streptozotocin Treatment on Adult Neurogenesis in the Rat Hippocampus
Volume: 12 Issue: 8
Author(s): Ping Sun, Ana Knezovic, Milena Parlak, Jacqueline Cuber, Margherita M. Karabeg, Jürgen Deckert, Peter Riederer, Qian Hua, Melita Salkovic-Petrisic and Angelika G. Schmitt
Affiliation:
关键词: 成年神经再生
摘要: Altered adult hippocampal neurogenesis (AN) plays a role in the etiopathology of Alzheimer’s disease (AD), a disorder characterized by a progressive loss of memory and spatial orientation impairment. Diabetes is shown to be one risk factor for the development of the sporadic form of AD (sAD), which affects >95% of AD patients. Streptozotocin intracerebroventricularily (STZ icv) treated rats, which develop an insulin-resistant brain state and learning and memory deficits preceding amyloid beta and tau pathology, may act as an appropriate animal model for sAD. The goal of our quantitative immunohistochemistry study was to compare short-term (1 month) and long-term (3 months) effects of STZ icv treatment on different AN stages. Applying MCM2 antibodies we quantified cell (e.g. stem cell) proliferation, by the use of NeuroD and DCX antibodies we analyzed immature neurons. BrdU incorporation with approximately 27 days of survival before sacrifice allowed us to quantify and identify surviving newborn cells. Performing co-localization studies with antibodies detecting BrdU and cell-type specific markers we could confirm that STZ treatment does not affect the differentiation fate of newly generated cells. Whereas STZ icv treatment does not seem to considerably influence cell proliferation over a shortterm period (1 month), in the long-term (3 months) it significantly decreased generation of immature and mature neurons. This reduction seen after 3 months was specific for the septal hippocampus, discussed to be important for spatial learning. Moreover, AN changes display the same timeline as the development of amyloid beta pathology in this animal model of sAD.
Export Options
About this article
Cite this article as:
Sun Ping, Knezovic Ana, Parlak Milena, Cuber Jacqueline, Karabeg M. Margherita, Deckert Jürgen, Riederer Peter, Hua Qian, Salkovic-Petrisic Melita and Schmitt G. Angelika, Long-Term Effects of Intracerebroventricular Streptozotocin Treatment on Adult Neurogenesis in the Rat Hippocampus, Current Alzheimer Research 2015; 12 (8) . https://dx.doi.org/10.2174/1567205012666150710112147
DOI https://dx.doi.org/10.2174/1567205012666150710112147 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Approaches for New TB Drugs
Current Respiratory Medicine Reviews Colloidal Drug Delivery Systems in Vaccine Delivery
Current Drug Targets West Nile Viral Meningoencephalitis in an Immunocompetent Female: A Case Report from Western Rajasthan, India
Infectious Disorders - Drug Targets Structure, Biological Properties and Applications of Marine-derived Polysaccharides
Current Organic Chemistry Lassa Virus Genome
Current Genomics A Critical and Comprehensive Insight on Heme Oxygenase and Related Products Including Carbon Monoxide, Bilirubin, Biliverdin and Ferritin in Type-1 and Type-2 Diabetes
Current Pharmaceutical Design Nanoemulsion for the Effective Treatment and Management of Anti-tubercular Drug Therapy
Recent Patents on Anti-Infective Drug Discovery Activation and Control of CNS Innate Immune Responses in Health and Diseases: A Balancing Act Finely Tuned by Neuroimmune Regulators (NIReg)
CNS & Neurological Disorders - Drug Targets Astrocytes and Inflammasome: A Possible Crosstalk in Neurological Diseases
Current Medicinal Chemistry Metallic Colloid Nanotechnology, Applications in Diagnosis and Therapeutics
Current Pharmaceutical Design Animal Models for the Evaluation of Theranostic Radiopharmaceuticals
Current Radiopharmaceuticals Small Neuroscience: The Nanostructure of the Central Nervous System and Emerging Nanotechnology Applications
Current Nanoscience Recent Advances in Azole Based Scaffolds as Anticandidal Agents
Letters in Drug Design & Discovery Blood Brain Barrier in Hypoxic-Ischemic Conditions
Current Neurovascular Research Occurrence of blaTEM and blaROB in Haemophilus species Causing Respiratory Tract Infections
Infectious Disorders - Drug Targets Linezolid in Children: Recent Patents and Advances
Recent Patents on Anti-Infective Drug Discovery Nanowired Drug Delivery of Antioxidant Compound H-290/51 Enhances Neuroprotection in Hyperthermia-Induced Neurotoxicity
CNS & Neurological Disorders - Drug Targets New Chemotherapy and Immunotherapy for Tuberculosis
Current Respiratory Medicine Reviews Immune Restoration Disease: A Consequence of Dysregulated Immune Responses After HAART
Current HIV Research An Overview of Chromatographic Analysis of Sulfonamides in Pharmaceutical Preparations and Biological Fluids
Current Pharmaceutical Analysis